FDA Watch: A New Blood Test for Accurate Alzheimer’s Detection
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.